These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7541288)

  • 1. Mechanisms of vascular remodeling in hypertension: role of autocrine-paracrine vasoactive factors.
    Gibbons GH
    Curr Opin Nephrol Hypertens; 1995 Mar; 4(2):189-96. PubMed ID: 7541288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular remodeling in hypertension: role of autocrine-paracrine factors.
    Gibbons GH
    Blood Press Suppl; 1995; 2():49-54. PubMed ID: 7582074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibition and vascular structure in hypertension.
    Gibbons GH
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S19-24. PubMed ID: 1725196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine-paracrine factors and vascular remodeling in hypertension.
    Gibbons GH
    Curr Opin Nephrol Hypertens; 1993 Mar; 2(2):291-8. PubMed ID: 7922189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine-paracrine mechanisms of vascular myocytes in systemic hypertension.
    Dzau VJ; Gibbons GH
    Am J Cardiol; 1987 Dec; 60(17):99I-103I. PubMed ID: 2891292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New perspectives in hypertension research. Potentials of vascular biology.
    Dzau VJ; Gibbons GH; Morishita R; Pratt RE
    Hypertension; 1994 Jun; 23(6 Pt 2):1132-40. PubMed ID: 8206603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell biology of vascular hypertrophy in systemic hypertension.
    Dzau VJ; Gibbons GH
    Am J Cardiol; 1988 Oct; 62(11):30G-35G. PubMed ID: 3051993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular remodeling and antihypertensive therapy: the example of cicletanine.
    Chabrier PE; Esanu A; Braquet P
    J Cardiovasc Pharmacol; 1993; 21 Suppl 1():S50-3. PubMed ID: 7681131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelium and growth factors in vascular remodeling of hypertension.
    Dzau VJ; Gibbons GH
    Hypertension; 1991 Nov; 18(5 Suppl):III115-21. PubMed ID: 1937673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial function as a determinant of vascular function and structure: a new therapeutic target.
    Gibbons GH
    Am J Cardiol; 1997 Mar; 79(5A):3-8. PubMed ID: 9127614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibition and vascular hypertrophy in hypertension.
    Gibbons GH; Dzau VJ
    Cardiovasc Drugs Ther; 1990 Feb; 4(1):237-42. PubMed ID: 2285616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasculoprotective and cardioprotective mechanisms of angiotensin-converting enzyme inhibition: the homeostatic balance between angiotensin II and nitric oxide.
    Gibbons GH
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-18-25. PubMed ID: 9422848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis and hypertension.
    le Noble FA; Stassen FR; Hacking WJ; Struijker Boudier HA
    J Hypertens; 1998 Nov; 16(11):1563-72. PubMed ID: 9856355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive treatment of graft coronary vascular disease: the potential role of vasodilator therapy.
    Gibbons GH
    J Heart Lung Transplant; 1992; 11(3 Pt 2):S22-7. PubMed ID: 1622995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphofunctional rearrangement of the hepatic vasculature in the pathogenesis of portal hypertension in liver cirrhosis].
    Garbuzenko DV
    Ter Arkh; 2014; 86(2):90-5. PubMed ID: 24772515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular stress response and endothelial vasoactive factors for vascular remodelling.
    Itoh H; Nakao K
    Diabetes Res Clin Pract; 1999 Sep; 45(2-3):83-8. PubMed ID: 10588359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role of exosome-mediated intercellular communication in vascular remodeling.
    Su SA; Xie Y; Fu Z; Wang Y; Wang JA; Xiang M
    Oncotarget; 2017 Apr; 8(15):25700-25712. PubMed ID: 28147325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remodeling of resistance vessel structure in essential hypertension.
    Mulvany MJ
    Curr Opin Nephrol Hypertens; 1993 Jan; 2(1):77-81. PubMed ID: 7922171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-hypertensive drugs associated with the improvement of endothelial function].
    Yoshimoto T; Hirata Y
    Nihon Rinsho; 2004 Jan; 62(1):128-34. PubMed ID: 14737845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vasoactive transmitters in the coronary circulation].
    Saetrum Opgaard O; Edvinsson L
    Tidsskr Nor Laegeforen; 1999 Aug; 119(19):2824-8. PubMed ID: 10494204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.